Blank Bio完成720万美元种子轮融资，并与PacBio达成战略合作。该公司利用批量RNA-seq数据训练基础模型，帮助制药公司设计更好的临床试验，从肿瘤转录组中构建预后和预测性生物标志物。
Congrats to @blankbio_ on their $7.2M seed and strategic collab with PacBio!
They're training foundation models on bulk RNA-seq data to help pharma teams design better clinical trials.
Good drugs fail when their effect gets lost in patient variability, or when trials enroll patients whose biology won't respond. Blank Bio's models learn that heterogeneity to build prognostic and predictive biomarkers from tumor transcriptomes.
https://t.co/JC0mMpXCjo
likes: 35 | retweets: 4 | replies: 7 | views: 6502